Gemmus Pharma Receives Series A Funding Round

  • Feed Type
  • Date
  • Company Name
    Gemmus Pharma
  • Mailing Address
    409 Illinois Street San Francisco, CA 94158
  • Company Description
    Gemmus Pharma is a drug development company founded in 2007 to commercialize in-licensed technology from a major pharmaceutical company. Gemmus’ lead candidate is a cardiovascular drug currently marketed in Asia that has been repurposed for use as a treatment for influenza.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Life Science Angels
  • Venture Investor
    BlueTree Allied Angels
  • Venture Investor
    Tech Coast Angels
  • Venture Investor
    Wilmington Investor Network
  • Venture Investor
    The Angels’ Forum

Trending on Xconomy